Skip to search formSkip to main contentSkip to account menu

Best Case Imputation Technique

Known as: BC 
A data imputation technique which populates missing values with the best possible outcome.
National Institutes of Health

Related topics

Related topics

2 relations
CDISC ADaM Derivation Type TerminologyClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
A meta-analysis of randomzied controlled trials comparing the effect of neoadjuvant chemotherapy with or without bevacizumab (Bev) in the treatment of breast cancer (BC).
577Background: There is currently no defined role of Bev in the treatment of BC, despite several studies suggesting activity in… 
2016
2016
Impact of CD8 stromal lymphocytes in BC patients with the addition of autologous dendritic CELL vaccination to neoadjuvant chemotherapy.
1081Background: Levels of tumor infiltrating lymphocytes (TILs) at diagnosis have shown to improve survival in TNBC and HER2… 
2012
2012
Abstract OT2-3-02: Phase Ib/II study of an oral PI3K/mTOR inhibitor plus letrozole compared with letrozole (L) in pre-operative setting in patients with Estrogen Receptor-positive, HER2-negative…
Background: Acquired hormone independent BC cell growth is associated with upregulation of the PI3K/mTOR pathway in vitro and in… 
2011
2011
Inter-comparison of Two Aethalometers for Aerosol Black Carbon Measurements
Recently, a real-time, pocket-sized aethalometer (microAeth model AE51) has been developed by Magee Scientific Inc. for measuring… 
2010
2010
[Bone marrow cellularity measurement by myelocrit].
BACKGROUND The bone marrow (BM) cellularity has been used as a major index for the evaluation of hematologic diseases and… 
2006
2006
A phase II study of AMN107, a novel inhibitor of Bcr-Abl, administered to imatinib-resistant or intolerant patients (pts) with Ph+ chronic myelogenous leukemia (CML) in blast crisis (BC) or relapsed…
6536 Background: AMN107 is a highly selective, aminopyrimidine which is 30-fold more potent in vitro than imatinib and active… 
2006
2006
A phase III randomized trial of adjuvant biochemotherapy (BC) versus interferon-α-2b (IFN) in patients (pts) with high risk for melanoma recurrence.
8003 Background: High-dose IFN (HDI) is associated with significant toxicity, and its clinical benefit as an adjuvant therapy for… 
2005
2005
Phase II genomics study in patients receiving ixabepilone as neoadjuvant treatment for breast cancer (BC): Preliminary efficacy and safety data
586 Background: Previous studies have confirmed the activity of ixabepilone (BMS-247550, a semi-synthetic analog of epothilone… 
Review
2004
Review
2004
Diagnostic Yield of Standard Brush Cytology (BC) Versus EUS-FNA for Pancreatic Cancer with Associated Malignant Biliary Stricture. Is It Time to Bury the Standard Biliary Brush?
Review
1984
Review
1984
FIRO-BC normative and psychometric data on 9- through 13-year-old children.
Study concerned principally with the need to provide normative and psychometric data for the FIRO-BC questionnaire. Reported are… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)